Showing results (191-200 of 265) with videos related to

Sort By:
Pageof 27
Platelets|July 31, 2010
Intra-individual variability in clopidogrel responsiveness in coronary artery disease patients under long term therapySébastien Arméro, Laurence Camoin Jau, Omar Omar Aït Mokhtar, et al.
Psychology, Health & Medicine|September 12, 2019
Parental disclosure of positive <i>BRCA1/2</i> mutation status to children 10 years after genetic testingJaïs Troïan, Thémis Apostolidis, Rajae Touzani, et al.
Nuclear Medicine Communications|June 3, 2011
Radiation doses to cohabitants of patients undergoing radioiodine ablation for thyroid cancer: poor compliance with radiation protection guidelines but low radiation exposureSophie Gabriel, Bardia Farman-Ara, Marc Bourrelly, et al.
Cancer Epidemiology|June 5, 2025
Burden of cervical cancer in Martinique, 2012-2021Rémi Houpert, Emmanuelle Sylvestre, Anne-Déborah Bouhnik, et al.
European Journal of Internal Medicine|March 6, 2012
Seasonal variations of systemic lupus erythematosus flares in southern FranceLaurent Chiche, Noémie Jourde, Claire Ulmann, et al.
Clinical Kidney Journal|August 25, 2022
Kidney involvement in hereditary transthyretin amyloidosis: a cohort study of 103 patientsJustine Solignac, Emilien Delmont, Etienne Fortanier, et al.
Nephrologie & Therapeutique|April 8, 2014
[Proliferative lupus nephritis treatment: practice survey in nephrology and internal medicine in France]Noémie Jourde-Chiche, Laurent Chiche, Julien Mancini, et al.
Acta Obstetricia Et Gynecologica Scandinavica|June 19, 2026
Predictive factors for the absence of high-grade intraepithelial lesions in LLETZ specimens following a prior histological diagnosisSophia Assirlikian, Julien Mancini, Charles-André Philip, et al.
Toxins|September 26, 2025
From Uremic Toxins to Hemodialysis Access Failure: IL-8 and MCP-1 Chemokines as a Link Between Endothelial Activation and AV Access ComplicationsRania Chermiti, Stanislas Bataille, Philippe Giaime, et al.
Contemporary Clinical Trials|April 17, 2007
Decision-making and breast cancer clinical trials: how experience challenges attitudesJulien Mancini, Jean Genève, Florence Dalenc, et al.
Pageof 27